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Over the last decades, the involvement of free radicals and
oxidative stress in the molecular mechanisms related to
ageing, cancer, atherosclerosis, neurodegenerative disorders,
diabetes, and inflammatory diseases became increasingly
clear. As a consequence, the interest on the potential
therapeutic applications of antioxidants has also increased.
Naturally occurring antioxidants as well as modified or
synthetic compounds have been screened for biological
activities that could be useful in the development of new
therapies for diverse conditions. Research using in vitro
(cell culture and chemical free radical-generating systems),
in vivo (animal models), and in silico models as well as
epidemiologic and different types of clinical studies have
been conducted by a great number of researchers worldwide,
in order to evaluate the possible therapeutic properties
of compounds with antioxidant activity. However, despite
the massive accumulation of evidence confirming the role
of oxidants in several pathological conditions (especially
cancer), the absolute majority of antioxidants developed for
clinical use has been proven ineffective.
In fact, a considerable number of compounds intended
to act as antioxidants in developing therapies were actually
reported to induce acute or long-term toxic effects, including
oxidative stress itself. One of the best documented examples
is the case of vitamin A, which was widely regarded as
an essential antioxidant component of the diet during the
1980 decade. A large clinical trial in the early 1990s The
Beta-Carotene and Retinol Efficacy Trial (CARET) evaluated
the effect of oral intake of beta-carotene and retinol in
18,314 men and women at high risk for lung cancer, but
it had to be discontinued due to increased incidence of
lung cancer, cardiovascular disease, and mortality. Following
this study, several papers demonstrated that according the
concentration, type of administration, and other factors,
vitamin A may act as a strong pro-oxidant to living cells.
Presently, some authors believe that even pro-oxidant agents
or processes, which were earlier recommended to be avoided,
may be important to maintain a healthy status, as low/mild
exposure to free radicals would help cells to maintain an
effective antioxidant defense system through physiological
mechanisms, in a process that could be called “oxidative
stress preconditioning.” Thus, it is clear that antioxidants and
antioxidant-based therapies must be cautiously addressed by
researchers in the field of redox biology.
One of this special issue papers investigates the effect
of the antioxidants trolox (hydrophilic analogue of alpha-
tocopherol) and dithiothreitol (DTT) on mouse locus
coeruleus neurons. This study demonstrates that pacemaker
currents and firing rates were heterogeneously modulated
in half of the neuronal population accessed, leading to the
hypothesis that these neuronal populations could be the first
ones affected in neurological disorders involving imbalance
in the oxidant/antioxidant content. Another paper of this
special issue presents an investigation on the potential of an
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ancient traditional medicine used in China, the pine pollen,
as a controller of cellular senescence through reduction
of oxidative stress and free radical-related formation of
advanced glycation endproducts (AGEs), which are relevant
inducers of chronic inflammation and neurodegenerative
processes. Another paper in this issue demonstrates that the
redox impairment caused in hippocampus by the molecular
constituent of amyloid plaques, the amyloid-beta peptide
(Aβ), is a result of increased Aβ cellular internalization and
deposition to mitochondria, and melatonin is an important
endogenous protector in this context. Another article is
a review on the possible mechanisms involved in the
antioxidant action of S-allylcysteine and old garlic extract,
which is enriched in S-allylcysteine, on different biological
systems, evaluating the potential clinical and therapeutic
applications of these products.
Another paper of this special issue reviews the clinical
literature on oxidative and antioxidant effects associated with
antidepressant agents and discusses their potential effects in
the treatment of major depressive disorder. This interesting
analysis suggests that augmentation of antioxidant defenses
may be one of the mechanisms underlying the neuroprotec-
tive effects of antidepressants in major depressive disorder
therapies. Another work published in this special issue
addresses an innovative topic, reviewing the recent advances
in therapies for neurodegenerative diseases that are based on
glutathione (GSH) delivery systems. Glutathione is regarded
as one of the major intracellular antioxidants, but its
limited stability and bioavailability pose serious difficulties
in the development of GSH-based therapies for clinical
application. Another work in this issue addresses the redox
and transcriptional effects of gases used in medicine (such
as carbon monoxide, hydrogen sulphide and hydrogen)
on antioxidant enzymes. Finally, another article of this
special issue is an updated review on the current state of
the use of antioxidants for therapies aimed to Alzheimer’s
disease. This comprehensive work summarizes many of the
aspects that must be taken into account when dealing with
antioxidants that exhibit a potential therapeutic application.
Many compounds first appear to be promising in animal
and in vitro models but fail to show relevant clinical results.
Also, the relationship between endogenous antioxidants
with disease prevention and/or prevalence revealed to be
predictive in some epidemiological and transversal studies
but were not observed in other similar works. The reasons
accounting for such inconsistency are still not clear but
certainly urge both caution and more extensive research on
this subject.
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